Open AccessA double-blind, randomized controlled trial to compare the effectiveness and safety of purified protein derivative of tuberculin antigen with Mycobacterium w vaccine in the treatment of multiple viral warts
Author(s) -
Somodyuti Chandra,
Abheek Sil,
Adrija Datta,
Santasmita Pal,
Nilay Kanti Das
Publication year - 2019
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/ijdvl.ijdvl_549_18
Subject(s) - medicine , tuberculin , adverse effect , purified protein derivative , randomized controlled trial , immunotherapy , mann–whitney u test , antigen , exact test , immunology , gastroenterology , tuberculosis , immune system , pathology
Present day therapeutic modalities for viral warts are mostly ablative in nature, limited by high recurrence rates and are unsuitable for numerous lesions. Immunotherapy has the potential to overcome these limitations.